A Phase 1 Study of E7080 in Subjects With Solid Tumor
Phase of Trial: Phase I
Latest Information Update: 30 May 2017
At a glance
- Drugs Lenvatinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 20 May 2016 New source identified and integrated (Japan Pharmaceutical Information Center - Clinical Trials Information; JapicCTI111382 )
- 13 Feb 2014 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov record.
- 16 Nov 2012 Planned End Date changed from 1 Aug 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.